Market Tracker

08/26 2:38pm ET

iShares Core S&P Mid-Cap ETF (IJH)

155.22
BATS BZX Real-Time Price
As of 2:38pm ET
 -1.15 / -0.74%
Today’s Change
121.12
Today|||52-Week Range
157.56
+11.41%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the S&P MidCap 400  (the "underlying index"), which measures the performance of the mid-capitalization sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.

Performance

1 month+1.31% 3 years+10.34%
3 months+6.07% 5 years+15.61%
1 year+17.71% Since inception+9.11%
Data through 08/26/2016

Quote Details

Previous close$156.37
Open day’s range155.11 – 157.56
Net asset value (NAV)156.38 (08/25/2016)
Daily volume211,956
Average volume (3 months)1,118,265
Data as of 2:38pm ET, 08/26/2016

Peer Comparisonvs. Mid-cap blend ETFs

 IJHCategory
Performance 5-yr return+15.61%+9.51%
Expense Gross exp ratio0.12%0.47%
Risk 5 year sharpe ratio0.870.79
Net assets$29.5B$2.6B
Average market cap$4.3B$6.8B
Average P/E21.018.5
Dividend / Share--0.24%

Competitors

VO Vanguard Mid-Cap Index Fund ETF Shares
JKG iShares Morningstar Mid-Cap ETF
KNOW Direxion All Cap Insider Sentiment Share...

Holdings

Top 5 Sectors
Portfolio weighting
Financial service 19.97%
Industrial materials 16.93%
Healthcare 10.48%
Consumer goods 9.02%
Consumer service 8.98%
Top 10 Holdings
Portfolio weighting
MTD Mettler-Toledo International Inc0.72%
DRE Duke Realty Corp0.65%
WWAV WhiteWave Foods Co0.64%
RMD ResMed Inc0.63%
INGR Ingredion Inc0.63%
CDK CDK Global Inc0.59%
COO Cooper Companies Inc0.58%
REG Regency Centers Corp0.57%
IDXX IDEXX Laboratories Inc0.55%
ARE Alexandria Real Estate Equities Inc0.54%